253 related articles for article (PubMed ID: 12237919)
1. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.
Olson JE; Janney CA; Rao RD; Cerhan JR; Kurtin PJ; Schiff D; Kaplan RS; O'Neill BP
Cancer; 2002 Oct; 95(7):1504-10. PubMed ID: 12237919
[TBL] [Abstract][Full Text] [Related]
2. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000?
Corn BW; Marcus SM; Topham A; Hauck W; Curran WJ
Cancer; 1997 Jun; 79(12):2409-13. PubMed ID: 9191531
[TBL] [Abstract][Full Text] [Related]
3. Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan.
Makino K; Nakamura H; Kino T; Takeshima H; Kuratsu J
Surg Neurol; 2006 Nov; 66(5):503-6. PubMed ID: 17084198
[TBL] [Abstract][Full Text] [Related]
4. Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.
Panageas KS; Elkin EB; DeAngelis LM; Ben-Porat L; Abrey LE
Cancer; 2005 Dec; 104(11):2466-72. PubMed ID: 16240449
[TBL] [Abstract][Full Text] [Related]
5. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
[TBL] [Abstract][Full Text] [Related]
6. Patterns of treatment in older adults with primary central nervous system lymphoma.
Panageas KS; Elkin EB; Ben-Porat L; Deangelis LM; Abrey LE
Cancer; 2007 Sep; 110(6):1338-44. PubMed ID: 17647247
[TBL] [Abstract][Full Text] [Related]
7. Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway.
Salvesen Haldorsen I; Aarseth JH; Hollender A; Larsen JL; Espeland A; Mella O
Acta Oncol; 2004; 43(6):520-9. PubMed ID: 15370608
[TBL] [Abstract][Full Text] [Related]
8. Decreasing incidence rates of primary central nervous system lymphoma.
Kadan-Lottick NS; Skluzacek MC; Gurney JG
Cancer; 2002 Jul; 95(1):193-202. PubMed ID: 12115333
[TBL] [Abstract][Full Text] [Related]
9. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for primary central nervous system lymphoma: a case-control study.
Schiff D; Suman VJ; Yang P; Rocca WA; O'Neill BP
Cancer; 1998 Mar; 82(5):975-82. PubMed ID: 9486590
[TBL] [Abstract][Full Text] [Related]
11. Male breast cancer: is the incidence increasing?
Hodgson NC; Button JH; Franceschi D; Moffat FL; Livingstone AS
Ann Surg Oncol; 2004 Aug; 11(8):751-5. PubMed ID: 15289238
[TBL] [Abstract][Full Text] [Related]
12. Primary central nervous system lymphoma: a study of clinicopathological features and trend in western India.
Pasricha S; Gupta A; Gawande J; Trivedi P; Patel D
Indian J Cancer; 2011; 48(2):199-203. PubMed ID: 21768666
[TBL] [Abstract][Full Text] [Related]
13. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
14. The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma.
O'Neill BP; Decker PA; Tieu C; Cerhan JR
Am J Hematol; 2013 Dec; 88(12):997-1000. PubMed ID: 23873804
[TBL] [Abstract][Full Text] [Related]
15. A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999.
Chakrabarti I; Cockburn M; Cozen W; Wang YP; Preston-Martin S
Cancer; 2005 Dec; 104(12):2798-806. PubMed ID: 16288487
[TBL] [Abstract][Full Text] [Related]
16. Descriptive epidemiology of non-Hodgkin's lymphoma in Oklahoma: 1997-2003.
Bliss A; Buriak S
J Okla State Med Assoc; 2008 Nov; 101(11):262-6. PubMed ID: 19113066
[TBL] [Abstract][Full Text] [Related]
17. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
Jemal A; Ward E; Thun MJ
Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.
Newell ME; Hoy JF; Cooper SG; DeGraaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI
Cancer; 2004 Jun; 100(12):2627-36. PubMed ID: 15197806
[TBL] [Abstract][Full Text] [Related]
19. Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was.
Sandin S; Hjalgrim H; Glimelius B; Rostgaard K; Pukkala E; Askling J
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1295-300. PubMed ID: 16835326
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system lymphoma: patterns of incidence in Indian population and effect of steroids on stereotactic biopsy yield.
Manoj N; Arivazhagan A; Mahadevan A; Bhat DI; Arvinda HR; Devi BI; Sampath S; Chandramouli BA
Neurol India; 2014; 62(1):19-25. PubMed ID: 24608449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]